Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-04-17

FDA Approved: VIGADRONE — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for VIGADRONE (vigabatrin) from Upsher-Smith Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VIGADRONE (VIGABATRIN)

Snippet

SUPPL AP for VIGADRONE (VIGABATRIN)